Home
RNAVAX BIO

RNAVAX BIO Market Share Analysis for June 2026

Dr. Gaurav Sahay with OSU's School of Pharmacy helps research messenger RNA vaccines, the same type being developed for COVID-19. PORTLAND, Ore. — As the world waits for a COVID-19 vaccine, a researcher in Oregon is lending perspective into how new vaccine technology could be approved for the first time. Dr. Gaurav Sahay is an associate

Industry: N/A

Domainrnavaxbio.com

Year Founded2020

Employees201 - 500

Annual Revenue--

RNAVAX BIO

RNAVAX BIO (including company regionals)

rnavaxbio.com

See more website traffic and engagement information

Total visits to RNAVAX BIO's top domains

Understand RNAVAX BIO market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in RNAVAX BIO's top domains

Analyze RNAVAX BIO engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on RNAVAX BIO's top domains

See how RNAVAX BIO keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

RNAVAX BIO top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by RNAVAX BIO

These are the website technologies, by industry, used by RNAVAX BIO top domains

Mobile (3)

Meta Viewport

Content Management System (2)

WordPress

Widget (2)

Twemoji

Advertising (1)

DoubleClick

More Technologies

5

See all

News & Signals from RNAVAX BIO

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRnavaxbio is developing technologies that can treat the deadly virus.Researchers at RNAVAX BIO are also working on technologies that can treat the deadly virus.